AI assistant
Sending…
Oxford Biomedica PLC — Director's Dealing 2016
Feb 29, 2016
5190_dirs_2016-02-29_da9625c3-485f-42ac-8168-b7f0e72c9794.html
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4760Q
Oxford Biomedica PLC
29 February 2016
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
| 1 | Issuer | Oxford BioMedica PLC |
| 2 | Reason for notification | Notification relates to DTR 3.1.2R |
| 3 | Name of PDMR | Martin Diggle |
| 4 | Connected person | Notification relates to following connected persons: Vulpes Life Sciences Fund |
| 5 | Notification in respect of | Notification in respect of holdings of persons in 4 above |
| 6 | Description of shares | Oxford BioMedica PLC ordinary shares of 1p each |
| 7 | Name of registered shareholders and number of shares | Vulpes Life Sciences Fund - 475,140,655 shares |
| 8 | Nature of transaction | Acquisition |
| 9 | Number of shares acquired | Vulpes Life Sciences Fund - 29,345 shares |
| 10 | Percentage of issued class acquired | Vulpes Life Sciences Fund - 0.01% |
| 11 | Shares disposed | N/A |
| 12 | Percentage of issued class disposed | N/A |
| 13/14 | Price per share of transactions, and date | Vulpes Life Sciences Fund 29,345 shares @ £0.066287 , 26 Feb 2016 |
| 15 | Total holding following notification and total percentage holding following notification | Vulpes Life Sciences Fund - 475,170,000 shares 17.58% |
| 16 | Date issuer informed | 29 Feb 2016 |
| 23 | Any additional information | None |
| 24 | Contact name and telephone number | T. Watts, Chief Financial Officer Oxford BioMedica +44 (0)1865 783000 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBDGDDSBDBGLC
More from Oxford Biomedica PLC
Regulatory Filings
2026
May 7
AGM Information
2026
May 7
Declaration of Voting Results & Voting Rights Announcements
2026
May 1
Regulatory Filings
2026
Apr 30
Share Issue/Capital Change
2026
Apr 27
Regulatory Filings
2026
Apr 13
Director's Dealing
2026
Apr 8
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 1
Annual Report
2026
Mar 30
Annual Report (ESEF)
2026
Mar 30